Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 9/20 | 0.42 |
| ▸ | CA2 | P00918 | 9/20 | 0.42 |
| ▸ | CA9 | Q16790 | 8/20 | 0.42 |
| ▸ | CA12 | O43570 | 3/20 | 0.42 |
| ▸ | CA7 | P43166 | 3/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.42 |
| ▸ | CA3 | P07451 | 2/20 | 0.42 |
| ▸ | CA4 | P22748 | 2/20 | 0.42 |
| ▸ | CA6 | P23280 | 2/20 | 0.42 |
| ▸ | CA5A | P35218 | 2/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.42 |
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 2/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8824233 | 1.00 | CA1 (0.42) | CA1CA2CA9CA12CA7 | |
| SCHEMBL8099158 | 0.98 | CA1 (0.43) | CA1CA2CA9CA12CA7 | |
| Ammonia Solution, Strong SCHEMBL8824248 | 0.97 | CA1 (0.42) | CA1CA2CA9CA12CA7 | |
| SCHEMBL21058283 | 0.97 | CA1 (0.42) | CA1CA2CA9CA12CA7 | |
| Ammonia Solution, Strong SCHEMBL8824130 | 0.97 | CA1 (0.42) | CA1CA2CA9CA12CA7 | |
| SCHEMBL8824122 | 0.97 | CA1 (0.42) | CA1CA2CA9CA12CA7 | |
| Ether SCHEMBL11758020 | 0.94 | USP2 (0.39) | CA1CA2CA9CA12CA7 | |
| Ether SCHEMBL4598201 | 0.93 | USP2 (0.40) | CA1CA2CA9CA12CA7 | |
| SCHEMBL11222011 | 0.92 | DGKA (0.46) | — | |
| E968 SCHEMBL8062338 | 0.91 | USP2 (0.36) | CA1CA2CA9CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090214648-A1 | PHARMACEUTICAL FORMULATIONS COMPRISING IBUPROFEN AND DIPHENHYDRAMINE | DR. REDDY'S LABORATORIES, INC. | 2009-08-27 | — | — | US | claimed |
| US-5393461-A | For use in cosmetics, paints, drugs,inks; mixing powder with anionic, cationic, amphoteric, nonionic surfactants, oils, solvents, wetting agents and water, emulsification | RTD CORPORATION (US) | 1995-02-28 | — | — | US | claimed |
| US-12589058-B2 | Method of dispersing hydrophobic substances in aqueous cleansing system | RENMATIX, INC. (US) | 2026-03-31 | — | — | US | disclosed |
| US-20240082117-A1 | Method of Dispersing Hydrophobic Substances in Aqueous Cleansing System | RENMATIX INC (US) | 2024-03-14 | — | — | US | disclosed |
| US-20210386631-A1 | Method of Dispersing Hydrophobic Substances in Aqueous Cleansing System | RENMATIX, INC. | 2021-12-16 | — | — | US | disclosed |
| WO-2021251987-A1 | METHOD OF DISPERSING HYDROPHOBIC SUBSTANCES IN AQUEOUS CLEANSING SYSTEM | RENMATIX, INC. (US) | 2021-12-16 | — | — | WO | disclosed |
| US-20090214648-A1 | PHARMACEUTICAL FORMULATIONS COMPRISING IBUPROFEN AND DIPHENHYDRAMINE | DR. REDDY'S LABORATORIES, INC. | 2009-08-27 | — | — | US | disclosed |
| US-20090030060-A1 | INTRAVAGINAL TREATMENT OF VAGINAL INFECTIONS WITH METRONIDAZOLE COMPOSITIONS | TOLMAR, INC. (US) | 2009-01-29 | — | — | US | disclosed |
| US-20080255498-A1 | Sensitizer Solutions, Systems, and Methods of Use | OROSCIENCE, INC. | 2008-10-16 | — | — | US | disclosed |
| EP-1933941-A2 | TREATMENT SYSTEMS FOR DELIVERY OF SENSITIZER SOLUTIONS | Houle, Philip R. (US) | 2008-06-25 | — | — | EP | disclosed |
| US-20070231358-A1 | INTRAVAGINAL TREATMENT OF VAGINAL INFECTIONS WITH METRONIDAZOLE COMPOSITIONS | TOLMAR, INC. | 2007-10-04 | — | — | US | disclosed |
| US-5393461-A | For use in cosmetics, paints, drugs,inks; mixing powder with anionic, cationic, amphoteric, nonionic surfactants, oils, solvents, wetting agents and water, emulsification | RTD CORPORATION (US) | 1995-02-28 | — | — | US | disclosed |
| EP-0404376-B1 | Buffered metronidazole compositions for intravaginal treatment of vaginal infections | CURATEK PHARMACEUTICALS (US) | 1994-03-23 | — | — | EP | disclosed |
| EP-0404376-A2 | Buffered metronidazole compositions for intravaginal treatment of vaginal infections | CURATEK PHARMACEUTICALS Limited Partnership (US) | 1990-12-27 | — | — | EP | disclosed |
| WO-1990014832-A1 | IMPROVED INTRAVAGINAL TREATMENT OF VAGINAL INFECTIONS WITH BUFFERED METRONIDAZOLE COMPOSITIONS | CURATEK PHARMACEUTICALS LIMITED PARTNERSHIP (US) | 1990-12-13 | — | — | WO | disclosed |
| US-4508634-A | REMOVAL OF PAINT, GREASE AND DIRT | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1985-04-02 | — | — | US | disclosed |
| US-4220152-A | Delivery system | PFIZER INC. (US) | 1980-09-02 | — | — | US | disclosed |
| US-4220153-A | Controlled release delivery system | PFIZER INC. (US) | 1980-09-02 | — | — | US | disclosed |
| US-4033895-A | Non-irritating shampoo compositions containing stearyl amine oxide | REVLON, INC. (US) | 1977-07-05 | — | — | US | disclosed |
| US-4017615-A | ESPECIALLY USEFUL FOR ANTIINFLAMMATORY TOPICAL CORTICOIDS | SYNTEX CORPORATION (PM) | 1977-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12589058-B2 | Method of dispersing hydrophobic substances in aqueous cleansing system | LIPA, STS, CEL | CA1 3902/4885CA2 2199/4885CA9 2688/4885 |
| US-20090214648-A1 | PHARMACEUTICAL FORMULATIONS COMPRISING IBUPROFEN AND DIPHENHYDRAMINE | HRH1, HRH4, HRH2 | CA1 3701/4885CA2 1164/4885CA9 2719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.